MatsukiyoCocokara & Co.
MSMKFOTCHealthcare● Active
$16.57
$-1.60(-8.81%)
Market Cap$6.6B
P/E Ratio—
52W High$21.22
52W Low$16.57
MatsukiyoCocokara & Co. (MSMKF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MSMKF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
$0.21
Est. $0.23 · -7.8%
Revenue
$1.75B
Est. $1.73B · +1.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
MSMKF reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.02
Rev. $0.33B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.02
Rev. Est.$0.33B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.22 | — | — | — | $1.81B | — |
| ▼ Q2 FY2026 | May 13, 2026 | $0.23 | $0.21 | -7.8% | $1.75B | $1.73B | +1.4% |
| ▼ Q1 FY2026 | Feb 13, 2026 | $0.27 | $0.26 | -4.7% | $1.85B | $1.85B | +0.4% |
| ▲ Q4 FY2025 | Nov 12, 2025 | $0.22 | $0.23 | +4.0% | $1.86B | $1.85B | +0.5% |
| ▼ Q3 FY2025 | Aug 11, 2025 | $0.24 | $0.22 | -6.7% | $1.89B | $1.87B | +1.1% |
| ▲ Q2 FY2025 | May 9, 2025 | $0.19 | $0.22 | +18.9% | $1.73B | $1.79B | -2.9% |
| ▲ Q1 FY2025 | Feb 14, 2025 | $0.25 | $0.26 | +1.4% | $1.75B | $1.73B | +1.1% |
| ▼ Q4 FY2024 | Nov 14, 2024 | $0.24 | $0.22 | -7.4% | $1.79B | $1.87B | -4.2% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.22
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
$0.21
EPS Est.
$0.23
EPS Surpr.
-7.8%
Revenue
$1.75B
Q1 FY2026
Feb 13, 2026Miss
EPS Actual
$0.26
EPS Est.
$0.27
EPS Surpr.
-4.7%
Revenue
$1.85B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
$0.23
EPS Est.
$0.22
EPS Surpr.
+4.0%
Revenue
$1.86B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
$0.22
EPS Est.
$0.24
EPS Surpr.
-6.7%
Revenue
$1.89B
Q2 FY2025
May 9, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.19
EPS Surpr.
+18.9%
Revenue
$1.73B
Q1 FY2025
Feb 14, 2025Beat
EPS Actual
$0.26
EPS Est.
$0.25
EPS Surpr.
+1.4%
Revenue
$1.75B
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
$0.22
EPS Est.
$0.24
EPS Surpr.
-7.4%
Revenue
$1.79B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $33.92 | $34.58 | $35.03 | 1 |
| Q4 FY2026 | $43.99 | $44.84 | $45.43 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $289B | $294B | $297B | 1 |
| Q4 FY2027 | $303B | $308B | $311B | 2 |
| Q3 FY2027 | $289B | $294B | $297B | 2 |
| Q2 FY2027 | $286B | $291B | $293B | 2 |
| Q1 FY2027 | $284B | $288B | $291B | 2 |
| Q4 FY2026 | $297B | $301B | $304B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -7.8% | $18.17 | $18.17 | +0.00% |
| ▼ Q1 FY2026 | Feb 13, 2026 | -4.7% | $18.17 | $18.17 | +0.00% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +4.0% | $19.81 | $19.81 | +0.00% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -6.7% | $21.20 | $21.20 | +0.00% |
| ▲ Q2 FY2025 | May 9, 2025 | +18.9% | $16.51 | $18.11 | +9.69% |
| ▲ Q1 FY2025 | Feb 14, 2025 | +1.4% | $16.01 | $16.01 | +0.00% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -7.4% | $13.80 | $13.80 | +0.00% |
| ▼ Q3 FY2024 | Aug 13, 2024 | -9.4% | $17.18 | $17.18 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 13, 2026
EPS Beat/Miss
-7.8%
Price Before
$18.17
Price After
$18.17
Q1 FY2026+0.00%
Report Date
Feb 13, 2026
EPS Beat/Miss
-4.7%
Price Before
$18.17
Price After
$18.17
Q4 FY2025+0.00%
Report Date
Nov 12, 2025
EPS Beat/Miss
+4.0%
Price Before
$19.81
Price After
$19.81
Q3 FY2025+0.00%
Report Date
Aug 11, 2025
EPS Beat/Miss
-6.7%
Price Before
$21.20
Price After
$21.20
Q2 FY2025+9.69%
Report Date
May 9, 2025
EPS Beat/Miss
+18.9%
Price Before
$16.51
Price After
$18.11
Q1 FY2025+0.00%
Report Date
Feb 14, 2025
EPS Beat/Miss
+1.4%
Price Before
$16.01
Price After
$16.01
Q4 FY2024+0.00%
Report Date
Nov 14, 2024
EPS Beat/Miss
-7.4%
Price Before
$13.80
Price After
$13.80
Q3 FY2024+0.00%
Report Date
Aug 13, 2024
EPS Beat/Miss
-9.4%
Price Before
$17.18
Price After
$17.18
Avg Beat Reaction+3.23%
Avg Miss Reaction+0.00%
Beat Rate3 / 8 quarters
Largest Move+9.69% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MSMKF ends December
MatsukiyoCocokara & Co. (MSMKF) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $0.21 — missing the analyst consensus of $0.23 by -7.8%. The next MSMKF earnings date is expected around September 1, 2026.
Each quarter, investors track MSMKF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MSMKF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MSMKF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MSMKF earnings · 5 questionsMatsukiyoCocokara & Co.'s next earnings report is expected around September 1, 2026. MSMKF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MSMKF historically reports after market close (AMC).
MSMKF earnings datewhen is MSMKF earningsMSMKF next earnings datewhen does MSMKF report earningsMSMKF earnings calendar
▸ Source: FMP · MatsukiyoCocokara & Co. SEC filings · US GAAP · MatsukiyoCocokara & Co. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026